Thyroid, cholesterol, and uric acid study for dialysis patients
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at thyroid function, cholesterol (lipid profile), and uric acid levels in people on hemodialysis. It aims to understand how these are connected, which could help improve monitoring and care for dialysis patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must have been receiving regular hemodialysis for at least 3 months.
- You cannot be taking medications for high cholesterol or high uric acid.
- You cannot have had an acute infection or been hospitalized in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well hemodialysis alone removes uric acid from the blood. It helps doctors decide if extra medicines are needed to lower uric acid in people on regular dialysis.
This trial tests whether taking a thyroid hormone supplement helps people who are on hemodialysis and have borderline-high thyroid lab results (high TSH but normal FT4). It’s studying whether treatment changes thyroid-related outcomes or health while on dialysis.
This study tests whether a cholesterol-lowering injection (alirocumab) helps people who are on regular dialysis. It aims to improve cholesterol control in a carefully selected group and tracks safety during treatment.
This study looks at how different types of dialysis fluid affect calcium buildup in the blood vessels of people with kidney disease on hemodialysis. It may help improve heart health for dialysis patients.
This study looks at how well the thyroid gland works in people who are on regular dialysis for kidney failure. By checking thyroid hormone levels, researchers hope to understand thyroid problems in this group and potentially improve their care.
This study checks thyroid function in people who are on long-term hemodialysis for kidney failure. It aims to see how common thyroid issues are in this group, which could help improve care.
Hear when a new Thyroid Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.